Dr. Speliotes focuses on nonalcoholic fatty liver disease, obesity and related metabolic diseases. This includes her collaboration through the Michigan Medicine-Peking University Health Science Center Joint Institute, which explores genetic and microbiome effects on non-alcoholic fatty liver disease and its medical complications in a Chinese population.
Elizabeth Speliotes, MD, PhD, MPH
Associate Professor of Computational Medicine and Bioinformatics
Associate Professor of Department of Internal Medicine
Countries of Interest: China